GSTM1 and anemia: Mixed-hypercholesterolemia referred to dyslipidemic participants mainly affected with hypercholesterolemia and abnormal profiles of lipidemic constituents: TGC, LDLC, HDLC (Figure 4A), in addition to the other MetS components in different percentages, i.e., hypothyroidism (HC–HT) (90.8%), diabetes (HC–DM) (66.1%), hypovitaminosis-D (HC–HD) (56.2%), hypertension (HC–HTN) (23.4%), anemia (HC–anemic Hb) (13.6%), hypercreatinemia (9.1%), and hypocreatinemia (2.3%) (Figure 4C).